title: [Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia].
authors.forename: A V
authors.initials: AV
authors.lastname: Pivnik
authors.forename: D L
authors.initials: DL
authors.lastname: Shtroiakovskiĭ
authors.forename: P V
authors.initials: PV
authors.lastname: Medvedev
authors.forename: T N
authors.initials: TN
authors.lastname: Moiseeva
authors.forename: N E
authors.initials: NE
authors.lastname: Shklovskiĭ-Kordi
authors.forename: A A
authors.initials: AA
authors.lastname: Skorokhod
mesh_terms: D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008081:Liposomes; D012008:Recurrence; D013997:Time Factors; D014212:Tretinoin / Q000008:administration & dosage
chemical_list: D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D008081:Liposomes; D014212:Tretinoin; D003630:Daunorubicin